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a b s t r a c t
This study investigated the anti-viral effects of the polyphenolic compounds Quercetin and Kaempherol
on the release of HTLV-1 from the surface of MT-2 cells. Atomic force microscopy (AFM) was used to scan
the surface of the MT-2 cells. MT-2 cells were ﬁxed with 100% methanol on round glass lamina or cleaved
mica and dried under UV light and laminar ﬂow. The images were captured on a Multimode equipment
monitored by a NanoScope IIId controller from Veeco Instruments Inc operated in tapping mode and
equippedwith phase-imaging hardware. The images demonstrated viral budding structures 131±57nm
in size, indicating profuse viral budding. Interestingly, cell-free viruses and budding structures visualizedT-2
tomic force microscopy (AFM)
uercetin
aempherol
on the surface of cellswere less commonwhenMT-2was incubatedwithQuercetin, andnoparticleswere
seen on the surface of cells incubated with Kaempherol. In summary, these data indicate that HTLV-1 is
budding constantly from the MT-2 cell surface and that polyphenolic compounds were able to reduce
this viral release. Biological samples were analyzed with crude cell preparations just after cultivation in
the presence of Quercetin and Kaempherol, showing that the AFM technique is a rapid and powerful tool
tivityfor analysis of antiviral ac
. Introduction
Human T-lymphotropic virus 1 (HTLV-1) was the ﬁrst human
etrovirus to be characterized (Popovic et al., 1982; Osame
t al., 1986; Gessain et al., 1985). After its discovery, HTLV-1
as also found to be the causative agent of adult T-cell lym-
homa/leukemia (ATL) (Hinuma et al., 1981; Takatsuki, 2005)
nd HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
HAM/TSP) (Osame et al., 1986; Gessain et al., 1985).
HTLV has some peculiarities, such as poor infectivity as a cell-
ree virus (Jones et al., 2008; Derse et al., 2001; Morozov and
eiss, 1999) and no observed cytopathic effect in cell culture
Vahlne, 2009). The fact that cell-free enveloped virions of HTLV-1
re undetectable in the serum of individuals infected with HTLV-
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1 and during in vitro culture of lymphocytes infected naturally
strongly supports these HTLV biological characteristics (Vahlne,
2009; Poiesz et al., 1980; Gallo, 2005). For that reason, cell lines
derived from peripheral blood mononuclear cells (PBMCs) of ATL
and HAM/TSP patients are used frequently for the analysis of
virus-induced pathogenesis, viral replication and morphogenesis,
as well as for the evaluation of anti-HTLV-1 antiviral effects of
drugs.
Concerning the research on new antiviral therapeutic
approaches, the majority of reports are based mostly on new
protocols for inhibition of receptor-binding assays (Kampani et al.,
2007) and the assessment of classical molecular and immunologi-
cal alterations in vitro and in vivo. For in vitro studies, the cell lines
MT-2, C91/PL, C5/MJ, HUT 102 and others have been evaluated
(Balestrieri et al., 2008).
MT-2 is a well-described HTLV-1-positive cell line that has
been used widely for investigations of HTLV-1 infection. MT-2 cells
exhibit profound expression of HTLV-1 proteins and mRNA coding
for HTLV-1 polyproteic precursors, and the molecular assessment
of HTLV-1 using MT-2 as a model has yielded frequently reliable
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nd consistent results (Morozov and Weiss, 1999; Balestrieri et al.,
008; Coelho-dos-Reis et al., 2009).
Nevertheless, there is a lack of simple and efﬁcient methods
o evaluate morphological changes in cells infected with HTLV-1
nd alterations in HTLV-1 structure that are applicable to patho-
enesis and antiviral therapy studies. In this respect, atomic force
icroscopy (AFM) is a powerful nanomicroscopy technique that
llows the determination of the dimensions of virus particles and
heir mechanical properties. The potential of AFM to characterize
iological samples has been well demonstrated over the last 17
ears. Although it is a relatively new technique, AFM has been used
n many studies on bacteriophages, animal and plant viruses, viral
rotein structures andbiomolecule interactions. This techniquehas
ontributed to knowledge on the biomedical and biotechnological
pplications of viral isolates around the world (Cidade et al., 2003;
ladnikoff et al., 2009; Malkin et al., 2003; Kuznetsov et al., 2008;
rindade et al., 2007).
Polyphenolic compounds are among the most ancient com-
ounds ever described and studied. Quercetin and Kaempherol,
wo polyphenolic compounds of the bioﬂavonoids group, have
een studied extensively in terms of their antioxidant, anti-
nﬂammatory andantiviral effects (Sonodaet al., 2004;Hämäläinen
t al., 2007; Min et al., 2007; Rogerio et al., 2007; Sharma et al.,
007; Chiang et al., 2003; Yu et al., 2009). Quercetin [IUPAC
ame: 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-
ne] and Kaempherol [IUPAC name: 3,5,7-trihydroxy-2-(4-
ydroxyphenyl)chromen-4-one] are bioﬂavonoids distributed
idely in the plant kingdom and are common constituents of most
dible fruits and vegetables (Chiang et al., 2003; Cao et al., 2009).
previous study has shown that a plant extract rich in polyphe-
olic compounds induces the expression of pro-apoptotic protein
evels and down-regulates anti-apoptotic protein expression in cell
ines infected with HTLV-1 (Harakeh et al., 2006). Nonetheless, the
peciﬁc polyphenolic compounds to which these effects should be
ttributed remain unknown. Induction of apoptosis by Quercetin
as also demonstrated inmurine leukemia virus cell lines (Yu et al.,
009).
The present study investigated the surface ofMT-2 aswell as the
TLV-1 released from those cells in the presence of Quercetin and
aempherol to evaluate the antiviral effects of these compounds. A
tandard AFM technique was developed and used to scan the MT-2
urface.
. Materials and methods
.1. Preparation of samples for AFM
.1.1. MT-2 culture
MT-2 cells were grown in a RPMI-1640 medium with 20%
etal bovine serum suspension supplemented with l-glutamine,
entamicin and penicillin at 37 ◦C, 5% CO2. After 72h of growth,
he suspension of cells was homogenized vigorously to dissolve
lumps, and differential centrifugation (100× g, 10min, 25 ◦C) was
sed to remove the remaining cell clusters. The cells were washed
wice with phosphate buffer solution and centrifuged (1000× g,
0min, 4 ◦C). The cells were resuspended in RPMI 20% fetal bovine
erum suspension supplemented as described before, and the sus-
ensionwas adjusted to approximately 1.0×106 cells/ml for all the
ssays performed.
.1.2. Quercetin and Kaempherol
The effects of Quercetin and Kaempherol on MT-2 cells were
ssessed after incubating the cells with either Quercetin or Kaem-
herol at 100M for 24h, resuspending the cells at a ﬁnal
oncentration of 1×106 cells/ml and seeding them in 24-well
lates.ological Methods 174 (2011) 47–52
2.1.3. Glass slides and mica preparation
Prior to microscopy, 13-mm round glass slides were washed
exhaustively with neutral detergent and incubated in distilled
water at 60 ◦C overnight to remove the remaining dirt and grease.
The glass slides were rinsed again with cold Milli Q water and
rinsed subsequently with 100% ethanol and dried under lami-
nar ﬂow. After drying, 500l of 1% poly-l-lysine was added to
the slides (Sigma–Aldrich, USA), and the slides were dried again
under laminar ﬂow. Cleaved mica (Ted Pella, Inc.) was also used
for cell analysis. MT-2 cells incubated with or without drugs
were centrifuged in a cytospin centrifugation apparatus (Jouan,
USA) (1000× g, 10min, 4 ◦C; 5.0×105 cells) onto the glass slide or
cleaved mica. After centrifugation, the cells were dehydrated suc-
cessivelywith 30%, 50% and 70% ethanol. The slideswere then ﬁxed
with cold methanol and dried under laminar ﬂow.
2.2. AFM scanning
AFM imaging was performed at room temperature on equip-
ment monitored by a NanoScope IIId controller from Veeco
Instruments Co. (Plainview, NY, USA) operated in tapping mode
and equipped with phase-imaging hardware. Commercial tapping
mode tips from NanosensorsTM with 228m long cantilevers, res-
onance frequencies of 75–98kHz, spring constants of 3.0–7.1N/m
and a nominal tip curvature radius of 5–10nm were used. The
regions scanned included both cells and matrix, but emphasis was
placed on the cell surface, considering the aim of this study. The
majority of AFM images presented are phase images because they
display the greatest amount of contrast and detail.
2.3. Data analysis for AFM scanning
The sizes, height anddepthof structures, indicatingHTLV-1viral
budding, free viral particles and membrane invaginations on the
surface after Quercetin or Kaempherol treatment, were measured
using the NanoScope software. This study was undertaken as three
independent experiments.
3. Results
3.1. Establishing the topological proﬁle of the MT-2 cell surface by
AFM
AFM was utilized to investigate the effects of Quercetin and
Kaempherol on the surface of MT-2 cells. Cells were incubated for
24h with these drugs at a concentration of 100M.
To characterize the MT-2 cell surface and HTLV-1 particles in
the presence or absence of Quercetin and Kaempherol, AFM images
were taken at different magniﬁcations. Fig. 1a shows a whole MT-
2 cell. In the MT-2 cell control (untreated cells), round structures
presenting an inward curve co-localized with spherical structures
resembling virus particles, indicating profuse HTLV-1 budding, as
shown in Fig. 1b, these structures were named viral budding units.
After 24h treatment with Kaempherol, no HTLV-1 free particles or
viral budding units were seen on the MT-2 cell surface (Fig. 1c).
Fig. 1d represents the MT-2 cell surface analysis after a 24-h treat-
ment with Quercetin. Abundant pores formed by invagination of
the membrane were seen; however, a large number of the pores
did not co-localizewith spherical structures, indicating diminished
HTLV-1budding compared to theuntreatedMT-2 cells. These pores
were also seen in MT-2 cells treated with Kaempherol. The use
of AFM allowed the reconstruction of a 3D image of this mem-
brane invagination displaying the diameter, height and depth of
a representative pore sample, as illustrated in Fig. 1e (12.04nm in
depth).
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Fig. 1. Gallery of AFM images from MT2 cells, a cell lineage that contains HTLV-1 provirus integrated (Human T-lymphotropic virus 1) and sheds virus particles. (a) Whole
M ed su
p viral p
Q emb
K n with
3
o
c
v
sT2 cell surface area (40×40m), amplitude image; (b) MT2 cell control untreat
hase image; (c) MT2 cell surface after 24h Kaempherol treatment – 100M; no
uercetin treatment – 100M, phase image; pores formed by invaginations of the m
aempherol showing topographic proﬁle of pore formed by membrane invaginatio
.2. HTLV-1 on the surface of MT-2 cells visualized by AFM
Whereasmost viruses spread by releasing large numbers of viri-
ns from each infected cell, HTLV-1 spreads efﬁciently between T
ells via a tight and highly organized cell–cell contact known as the
irological synapse. T lymphocytes infectedwithHTLV-1store tran-
iently viral particles as carbohydrate-rich extracellular assembliesrface showing rounded budding structures and free virus particles (5.2×5.2m),
article is seen in this picture (4.6×4.6m), phase image; (d) MT2 cell after 24h
rane are seen on entire surface of MT2 cell (4.6×4.6m); (e) MT2 cell treated with
12.04nm of depth, height image.
that are held together and attached to the cell surface by virally
induced extracellular matrix components, as shown recently by
Pais-Correia et al. (2010), and referred to as HTLV-1 bioﬁlm-like
structures.
An AFM image of the HTLV-1 budding structures and HTLV-1
free particles is shown in Fig. 2. All the cells scanned in the indepen-
dent experiments showed large numbers of these structures with
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Fig. 2. Analisys of HTLV-1 budding structures and viral free particles on MT2 cell surface. (a) MT2 control cell surface showing many rounded viral budding structures with
viral like particles inside, in the right side of the ﬁgure, a spherical particle resembling virus is measured as an example (150nm diameter) (5.2×2.4m); (b) viral budding
structures and virus free particle (indicated with arrows – AFM measurements: 1 – 128nm; 2 – 134nm; 3 – 78nm; 4 – 90nm and 5 – 95nm; 2.9×1.4m); (c) distribution
o tal of
p mages
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ff virus particles diameter in MT2 control cell and MT2 treated with Quercetin. A to
articles showed shortest measurements compared to MT2 control untreated. All i
imilar and consistent morphology. The surface of MT-2 control
ells showed many rounded viral budding structures with virus-
ike particles inside the membrane projections and invaginations
Fig. 2a); in Fig. 2b, viral budding structures and free virus particles
indicated with arrows and with AFM measurements ranging from
8 to 134nm) can be seen. A total of 81 particles were examined
mean=131±57nm; range 33.7–292.7nm). In Quercetin-treated
ells, the virus particles were smaller (mean=97.56±41.67nm;
ange 33.7–164.4nm) than those from the untreated MT-2 control
ells (mean=161.96±51.43nm; range 67.4–292.7nm). However,
or both MT-2 cells treated with Quercetin and untreated cells,81 particles were examined (mean=131±57nm). In Quercetin treated cells, virus
displayed are phase images.
over 50% of the total virus particles examined were 97–165nm
in size, with a mean particle size of 133±20nm. It is important
to emphasize the antiviral effect observed with the polyphenolic
compounds; Quercetin treatment of MT-2 cells reduced viral bud-
ding, and no virus was seen in any of the experiments conducted
with Kaempherol.4. Discussion
The discovery of HTLV represented the ﬁrst and most important
event that paved the way for researchers to understand infec-
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ion of humans by retroviruses (Gallo, 2005) and to discover HIV.
he development of inhibitors of reverse transcriptase provided a
ramework for drug development against HIV. Nevertheless, HTLV
ntiviral therapy still remains obscure and poorly investigated (Oh
nd Jacobson, 2008). The lack of clear evidence on how HTLV-1
preads within and between hosts and the absence of consistent
nd reliable biomarkers of disease progression discouraged the use
f antiviral drugs for the control of diseases associatedwithHTLV-1
Balestrieri et al., 2008).
Recently, better understanding of direct cell-to-cell transmis-
ion of the virus by virological synapses and by proliferation of
nfected cells has yielded new guidance and perspective for studies
imed at identifying compounds that inhibit efﬁciently the HTLV-1
eplication cycle or even compounds that impair the ability of cells
nfected with HTLV-1 to persist and generate infected offspring in
hehost. Recentprogress inHTLV-1 transmission, particularly stud-
es demonstrating mechanisms involved in cell-free virus infection
f dendritic cells (Jones et al., 2008; Jain et al., 2009), reinforces the
mportance of identify drugs with both antiviral and immunomod-
latory activity.
The MT-2 cell line was derived from bone marrow CD41
-lymphocytes from a healthy donor after co-cultivation with
eukemia cells of an Adult T cell leukemia patient (Miyoshi et al.,
981).While evaluating this cellmodel (MT-2 cell line transformed
y HTLV-1), Morozov and Weiss (1999) showed that there is one
omplete provirus and seven defective proviruses in MT-2 cells.
hese investigators puriﬁed the viruses using sucrose gradients and
rovided reliable evidence of a mixed population of virus particles
eleased from MT-2 cells: light particles (density∼1.12g/cm3) and
eavy or classical particles (density∼1.16g/cm3) containing the
tandard HTLV-1 protein pattern.
Timar et al. (1987) used immunoelectron microscopy to exam-
ne HTLV-1 particles in C91/PL cells (infected permanently with
TLV-1) and HOS/PL cells (a human osteosarcoma cell line derivate
roducing HTLV-1) and observed particles ranged from 80 to
50nm in diameter. Recently, Majorovits et al. (2008) visualized
TLV-1-induced virological synapses by electron tomography on
D4+ T cells infected naturally with HTLV-1 and the HTLV-1-
nfected MS9 cell line. The diameters of HTLV-1 particles measured
n the viral synapses on naturally infected CD4+ T cells averaged
05nm (range 62–173nm; n=44), and the particles derived from
he MS9 cell line were larger, presenting a mean diameter of
26nm (range 46–246nm; n=151). These ﬁndings were very sim-
lar to those obtained by AFM in the present study that showed a
ean diameter of 131±57nm (range 33.7–292.7nm; n=81). As
bserved for some retroviruses in many previous studies, the size
f HTLV-1 varies from 30 to 237nm.
After Kaempherol treatment, the MT-2 cell surface examined by
FM showed no viral particle budding. Quercetin treatment dimin-
shed the budding in comparison to untreated MT-2 cells, and the
irus particles were smaller (mean=97.56±41.67nm) than those
rom untreated MT-2 control cells (mean=161.96±51.43nm),
hich way indicate a defect in particle assembly. Grigsby et al.
2010) developed a codon-optimized HTLV-1 Gag as a model sys-
emtoanalyzeHTLV-1produced in transient infectionusinganovel
iophysical technology, Fluorescence of Fluctuation Spectroscopy
FFS), which provides information about particle size and protein
toichiometry. Considering that Gag polyprotein, the main retro-
irus structural protein, is composed of three functional domains
hose cleavage results in particle maturation, these investigators
ave produced immature virus-like particles (VLP) and determined
n average Gag copy number of 510±50 (range 300–880). In a sim-
lar study conducted with HIV-1, the Gag number increased when
efects that can interfere with the particle infectivity, transmission
nd pathogenesis were introduced during budding (Carlson et al.,
008).ological Methods 174 (2011) 47–52 51
Although HTLV-1 was the ﬁrst human retroviruses to be discov-
ered, very little is known about its virion morphology and particle
assembly. Pais-Correia et al. (2010) reported that T lymphocytes
infected with HTLV-1 store transiently viral particles as extracellu-
lar assemblies that areheld together andattached to the cell surface
by virally induced extracellular matrix components, called HTLV-
1 bioﬁlm-like structures. According to these researchers, removal
of these cell surface particles could reduce the ability of HTLV-1-
producing cells to infect target cells. Compounds with the selective
cytotoxic effect on infected cells and which diminish the formation
of this viral bioﬁlm would have important potential therapeutic
application.
The present study provides evidence that Quercetin and Kaem-
pherolwere able to diminish and inhibit, respectively, viral release,
which was found to be abundant on the surface of MT-2 cells.
Ongoing investigations seek toverifywhetherQuercetinandKaem-
pherol induce cell death by restoring the apoptotic mechanisms
of MT-2 cells. In addition, Quercetin and Kaempherol were found
to inhibit viral mRNA and viral proteins, indicating that the com-
pounds may have an antiviral activity that could be responsible for
the selective MT-2 cell death (unpublished data).
In recent years, AFM has provided a broad range of new oppor-
tunities for viewing and manipulating biological systems in their
native environments, which can be useful for investigating host-
pathogen interactions. Studies based on viral pathogenesis, and
consequently cell–virus interactions, require the knowledge of the
three-dimensional structure of the macromolecules involved. In
the case of viral infections, such studies involve detailed knowledge
of virion composition and architecture.
However, studies focusing on the detailed organization of
human and animal viruses can be difﬁcult to perform due to the
fragile and often heterogeneous structure of these viruses and
the difﬁculty in obtaining adequate amounts of puriﬁed particles
(Malkin et al., 2002; Plomp et al., 2002; Kuznetsov et al., 2001).
In the case of HTLV-1, it is even more difﬁcult to produce, purify
and quantify viral particles because none of the classical virological
techniques based on cytopathic effect observation for viral titration
are applicable to HTLV. Thus, the AFM technique is especially valu-
able for virus investigations as it provides a rapid, simple and a
safe tool for virus characterization using small and relatively crude
preparations (Trindade et al., 2007).
In the present study, for instance, a relatively straightforward
and undemanding preparation of sample was conducted for AFM
imaging without using toxic and dangerous reagents, such as glu-
taraldehyde andosmium tetroxide, to dehydrate, ﬁx or stabilize the
sample. It is important to mention, however, that rigorous safety
procedures are essential when handling an MT-2 cell culture. AFM
imagingwas shown tobe a reliable and consistent technique toper-
form viral assessment on infected cells, is therefore recommend for
future viral research investigations.
The results indicate that HTLV-1 is budding constantly from the
MT-2 cell surface, and viral release was visualized successfully by
AFM. AFM was also valuable in revealing that two polyphenolic
compounds, Quercetin and Kaempherol, were able to reduce this
viral release, suggesting their potential use as antiviral compounds,
which is valuable for future studies on ﬁnding new and alternative
treatment approaches for HTLV-1-related diseases.
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